ScienceAlert on MSN
First-of-Its-Kind Treatment Boosts Vision in Human Trial, Scientists Report
Taking a photo of a friend? You've probably got their face centered and focused. Driving down a highway? Eyes on the road.
The trial is a phase 1/2 open-label, ascending-dose study of the safety and efficacy of OPGx-LCA5. Recently, the company ...
Bestrophinopathy and Vitelliform Macular Dystrophy represent a spectrum of inherited retinal disorders predominantly associated with mutations in the BEST1 gene. These conditions are characterised by ...
Vitelliform macular dystrophy, also known as Best disease, is one of a group of vision-robbing conditions called bestrophinopathies that affect children and young adults. Caused by inherited mutations ...
8don MSN
Reducing inflammation may protect against early age-related macular degeneration-like vision loss
University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...
The US company investigating the use of human embryonic stem cells to treat a type of macular dystrophy expands its clinical trials to the UK. A series of rodent experiments showed that even with ...
News-Medical.Net on MSN
Inflammation control can protect against AMD-like retinal damage
University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback